A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
Sumathi Sivapalasingam, David J. Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner, Romana Hossain, Adnan Mahmood, Angeliki Giannelou, Selin Somersan-Karakaya, Meagan O’Brien, Anita Boyapati, Janie Parrino, Bret Musser, Emily Labriola-Tompkins, Divya Ramesh, Lisa A. Purcell, Daya Gulabani, Wendy Kampman, Alpana Waldron, Michelle Ng Gong, Suraj Saggar, Steven J. Sperber, Vidya Menon, David K. Stein, Magdalena E. Sobieszczyk, William Park, Judith A. Aberg, Samuel M. Brown, Jack A. Kosmicki, Julie E. Horowitz, Manuel A. Ferreira, Aris Baras, Bari Kowal, A. Thomas DiCioccio, Bolanle Akinlade, Michael C. Nivens, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the Sarilumab-COVID-19 Study Team
medRxiv 2021.05.13.21256973; doi: https://doi.org/10.1101/2021.05.13.21256973
